Hoberman Kenneth 4
4 · STEMLINE THERAPEUTICS INC · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Hoberman Kenneth
Chief Operating Officer
Transactions
- Award
Common Stock
2020-02-10+208,417→ 809,502 total
Footnotes (2)
- [F1]The 208,417 restricted shares will vest in three installments as follows: 69,473 shares on April 14, 2021; 69,472 shares on March 30, 2022; and 69,472 shares on January 18, 2023.
- [F2]Of the listed shares, 445,724 shares are restricted stock.